What Drug Has the Highest Relapse Rate?

A Guide to Alcohol and Substance Relapse Rate from Icarus Wellness & Recovery

Relapse is one of the most common and misunderstood parts of the recovery process.

If you or someone you love is struggling with substance use, understanding which drugs carry the greatest relapse risk-and what you can do about it-can shape every decision you make going forward.

This guide breaks down addiction relapse rates by drug type, explains why they vary, and offers practical relapse prevention strategies informed by the clinical team at Icarus Wellness and Recovery.

Quick Takeaways

• Research does not identify one substance as having the universally highest relapse rate. Estimates vary substantially according to how relapse is defined, the population studied, the treatment received, and the length of follow-up.
• Opioid, methamphetamine, alcohol, cocaine, and cannabis use disorders can all involve a return to use. Individual risk depends on factors such as substance use history, treatment engagement, co-occurring conditions, social support, housing stability, and access to continuing care.
• Some studies illustrate how widely outcomes can differ. One methamphetamine treatment study found that 61% of participants returned to use within one year, while a recent review of opioid studies found estimates ranging from 0% to 95% across different treatment and follow-up conditions.
• A return to opioid use can be especially dangerous because tolerance may decrease during abstinence and illegally manufactured fentanyl is prevalent in the drug supply. Medications, behavioral treatment, overdose-prevention planning, and continuing support can reduce risk.

What Drug Has the Highest Relapse Rate? A Brief Answer

There is no scientifically reliable answer that applies to every person or treatment setting. Opioid, methamphetamine, and alcohol use disorders are frequently associated with substantial rates of return to use, but research does not support ranking them with one universal set of percentages.

Published estimates differ because studies measure different outcomes. Some count any substance use after abstinence, while others count sustained or weekly use. Studies also differ in treatment type, medication use, participant characteristics, and follow-up duration. Cannabis and cocaine can also involve a return to use, but the available evidence does not support describing their relapse risk with a single universal percentage.

These numbers vary because relapse rates depend on several factors: addiction longevity, rehab quality, co-occurring mental health disorders, tolerance levels, and available support systems. Regardless of drug type, relapse is a treatable event. At Icarus Wellness and Recovery, clinicians use these statistics to design stronger relapse prevention plans, not to discourage anyone from seeking help.

What Is Relapse and How Is It Different from a Lapse or Slip?

Relapse means a sustained return to substance use after a period of abstinence or reduced use. It is considered a common aspect of the recovery process, not an endpoint. Relapse can occur at any stage of recovery, whether someone has been sober for weeks or years.

A lapse (sometimes called a slip) is a brief return to substance use, for example, one night of drinking or taking a single pill, followed by a quick return to recovery goals. A relapse, by contrast, is a full return to addictive behaviors, often with the person abandoning their treatment plan or support structures.

Research reports different relapse rates in part because definitions vary across studies. From the Icarus clinical perspective, both lapses and relapses are signals to adjust care plans, not reasons for shame. Some relapse-prevention models describe emotional, mental, and physical stages, but these stages are not a universal diagnostic sequence.

As a reminder: Changes in mood, sleep, coping, social engagement, or thoughts about substance use may serve as warning signs and should prompt discussion with a treatment professional or recovery support person.

Why Do Relapse Rates Vary So Much by Drug Type?

Different substances interact with the brain and body in distinct ways, which helps explain why relapse rates for heroin or meth look very different from those for alcohol, marijuana, or cocaine.

Core drivers include:

• Pharmacology and brain changes. Changes in brain chemistry due to drug use can provoke intense cravings. Drugs that build rapid tolerance and produce severe withdrawal symptoms tend to carry higher relapse risk.
• Route of administration. Smoked or injected drugs deliver faster onset, stronger conditioning, and more reinforced behaviors-all of which influence relapse potential.
• Social acceptance and availability. Legal alcohol is everywhere; environmental cues can trigger intense cravings leading to relapse even years into sobriety.
• Co-occurring mental health conditions. Co-occurring mental health disorders like PTSD, bipolar disorder, and depression elevate the risk of relapse when left untreated.
• Quality and duration of treatment. Short detox alone is linked to much higher relapse rates than comprehensive, long-term recovery support, especially when care is matched to individual needs using ASAM levels of care for addiction treatment. Social pressure and the social environment also influence the likelihood of relapse significantly.
• Strength of support systems. Lack of support increases the risk of relapse after treatment. Stable housing, employment, and peer recovery groups all reduce risk.

At Icarus Wellness and Recovery, clinicians assess all of these external factors at intake to estimate individual risk and personalize relapse prevention strategies, drawing on a range of accredited treatment programs in Idaho to match each person with the right level of care.

What are the Substances With the Highest Relapse Rates: What the Research Shows

Research does not provide a dependable ranking of substances by relapse rate. The following findings illustrate why percentages need to be interpreted within the conditions of each study:

• Opioids: A 2025 systematic review examined ten studies of adults discharged from non-hospital residential treatment for opioid use disorder. Reported return-to-use rates ranged from 0% to 95%, with follow-up periods ranging from one to six months. The researchers found substantial differences in treatment, sample size, relapse definitions, and measurement methods. The review therefore does not support using one percentage as the relapse rate for opioid use disorder.
• Methamphetamine: In a study of 350 people treated for methamphetamine use, 61% returned to methamphetamine use within the first year after discharge. Longer treatment and participation in continuing treatment or self-help services were associated with longer periods of abstinence. This result describes one treatment-system sample and should not be treated as a universal methamphetamine relapse rate.
• Alcohol: One study of a high-risk treatment cohort reported that approximately two-thirds returned to alcohol use within six months. Alcohol outcomes vary according to disorder severity, treatment, smoking status, co-occurring symptoms, follow-up period, and the definition of relapse.
• Cocaine: A national study of 1,605 cocaine-dependent patients found that 23.5% reported weekly or more frequent cocaine use during the year after treatment. This does not mean that participants had a 23% chance of relapsing every week. Longer treatment participation was associated with more favorable outcomes in that study.

Available studies use differing definitions and populations, so a single general cannabis relapse rate should not be inferred. More broadly, these findings show why relapse statistics should be used to explain population-level patterns rather than predict what will happen to an individual.

Opioids and Alcohol: Why do These Substances Drive Some of the Highest Relapse Rates?

Opioids and alcohol are singled out for their combined biological, psychological, and social impact on the person using them.

Opioids affect reward, pain, stress, and withdrawal systems, and cravings or withdrawal symptoms can contribute to return-to-use risk. Abstinence may also reduce opioid tolerance, increasing the risk of overdose if a person returns to a previously used amount.

Illegally manufactured fentanyl adds further risk because it is prevalent in the illicit drug supply and may be present without the person’s knowledge. Pharmaceutical fentanyl is approximately 50 to 100 times more potent than morphine, although the potency and composition of illicit products can be unpredictable.

Alcohol is legal, heavily marketed, and deeply woven into social events, workplaces, and personal relationships. Some people report using alcohol to cope with depression, trauma symptoms, anxiety, stress, or other distress.

When these concerns are present, addressing both alcohol use and mental health needs may strengthen the treatment plan. Repeated cycles of alcohol relapse worsen health, relationships, and employment, yet recovery remains possible at every stage.

From the Icarus clinical perspective, people who relapse on opioids or alcohol are not starting over from zero. Each attempt builds insight into triggers and teaches new coping skills.

How Mental Health, Environment, and Support Systems Affect Relapse Rates

Drug type is only part of the story. Mental health, life stress, and social context often determine whether someone’s relapse risk is high or low.

• Mental health: Conditions such as depression, anxiety disorders, PTSD, and personality disorders increase risk if left untreated. Self-medication-using substances to numb painful feelings or trauma memories-can quickly lead back to drug abuse or substance abuse without integrated care. Stress is a common trigger for addiction relapse, and low self-efficacy (doubting your ability to cope without substances) compounds this risk.
• Environment and social networks: Living where substances are used, ongoing exposure to dealers or using friends, or high-stress workplaces make preventing relapse much harder. By contrast, stable housing, supportive family, peer recovery meetings, and sober social activities are associated with lower relapse rates and a better chance of achieving long-term recovery.
• Access to quality treatment: Brief detox alone is associated with higher relapse rates compared to ongoing care. At Icarus Wellness and Recovery, clinicians prioritize integrated care-combining mental health treatment, family support, and substance use disorder services, including residential inpatient rehab programs in Boise-to address all major relapse risk factors at once, helping each person maintain sobriety through personal challenges.

Relapse Prevention: Evidence-Based Ways to Lower High Relapse Rates

Relapse risk is not fixed. Evidence-based behavioral treatment, appropriate medications, continuing care, recovery support, and practical planning can reduce risk, although no intervention can guarantee that a return to use will not occur.

Essential tools used at Icarus and in modern treatment include:

• Cognitive-behavioral therapy can help people identify substance-related thoughts, cues, and high-risk situations while developing coping and problem-solving skills. Research supports CBT as a treatment for substance use disorders, although outcomes vary by substance, treatment format, and the other services provided.
• Motivational interviewing is used to strengthen internal motivation for sobriety and resolve ambivalence about change.
• Medications may be included when clinically appropriate. Buprenorphine, methadone, and extended-release naltrexone are used for opioid use disorder, while medications such as naltrexone and acamprosate may be used for alcohol use disorder. The benefits and risks differ by medication and patient. Many forms of insurance, TRICARE may cover substance use disorder treatment and medication-assisted treatment when applicable requirements are met, but eligibility, authorization, provider, and plan rules should be verified.

Practical strategies readers can apply:

• Developing a relapse prevention plan listing personal triggers, early warning signs, and specific actions to take, such as calling a support person, attending a meeting, or scheduling an extra therapy session.
• Building daily self-care routines that support recovery, such as regular sleep, physical activity, balanced meals, therapy, peer support, and meaningful routines. These habits can support overall health during recovery, but they should not be presented as substitutes for clinical treatment.
• Learning to manage stress with mindfulness, breathing techniques, or trauma-informed therapies instead of turning back to substance use. Identifying triggers is an important part of relapse-prevention planning.

Family and loved ones can play an important role by learning to spot warning signs, responding without judgment, and encouraging the person to seek support quickly when risk rises.

What Loved Ones Can Do When Relapse Happens

If you are a family member or partner seeing signs of a potential relapse, know that your support can make a real difference. Recognize these warning signs:

• Changes in mood, sleep, or appetite
• Withdrawing from family, support groups, or hobbies
• Unexplained money problems, secretive behavior, or contact with old using friends
• Physical signs of alcohol, opioid, or other drugs effects or symptoms of use

When relapse or a strong lapse occurs:

• Stay calm and non-confrontational; focus on safety first, especially the risk of overdose with opioids.
• Encourage the person to reconnect with their therapist, recovery coach, or treatment program quickly rather than waiting for things to worsen.
• If overdose is suspected (especially with fentanyl or heroin), call emergency services immediately and administer naloxone if available.

Reaching Out for Support Following Relapse is a Sign of Strength

Icarus Wellness and Recovery works with families through education sessions, support groups, and involvement in treatment planning to help prevent relapse and respond effectively when it occurs, and can also walk you through private pay rehab options if you prefer care without insurance limitations (though we also accept many forms of Medicaid and private insurance for coverage as well).

A relapse does not erase progress. Many people achieve stable long-term recovery after one or more relapses when they have consistent, evidence-based support and seek support again. Both the severity of the return to use and the speed of the response matter.

Prompt support is especially important when opioids, overdose risk, dangerous withdrawal, self-harm, or other immediate safety concerns are involved.

All calls are confidential, so please reach out today for options and assistance.

FAQ: Common Questions About High Relapse Rates and Recovery

These questions address concerns that may not have been fully covered above, based on what individuals and families most often ask the Icarus clinical team.

Does a higher relapse rate mean some drugs are impossible to quit?

No. Even for substances with very high relapse rates-heroin, fentanyl, methamphetamine- long-term recovery is absolutely possible. High percentages describe how commonly individuals relapse, not whether recovery can succeed.

Many people achieve stable sobriety after several attempts, especially when treatment addresses mental health, trauma, and environment alongside detox. Focus on building the most robust support system and relapse prevention plan you can, rather than comparing yourself to statistics. Risk is not destiny, and every person deserves the chance to achieve well-being in recovery.

How long do I need support to keep my relapse risk low?

Research from the National Institute on Drug Abuse suggests relapse risk is highest in the first 6–12 months after stopping substance use, but benefits continue growing when people stay engaged in support for several years.

A practical framework: intensive treatment first, then step-down levels of care-outpatient therapy, medication management, support groups, alumni programs-for as long as it remains helpful. Some individuals choose to stay connected to recovery communities indefinitely, similar to how people with diabetes or other chronic diseases maintain ongoing medical follow-up to analyze relapse rates and adjust care.

Can you really prevent relapse, or only reduce the risk?

No approach can guarantee someone will never relapse. Evidence-based treatment and continuing support can reduce the likelihood of a return to use and help someone respond sooner when warning signs or substance use occur. Learning early warning signs, having an action plan, using appropriate medications, and involving family or trusted friends can support recovery.

Clinically, Icarus views relapse prevention as both reducing the likelihood of use and limiting harm and duration if a return to substance use happens. The goal is to impact relapse rates through every available tool.

Is relapse a sign that treatment “didn’t work” and should be abandoned?

Relapse is not proof that treatment failed. It often shows that the current plan needs adjustment-more intensive support, different medication, or added mental health care.

Compare relapse in substance use disorders to symptom flares in other chronic illnesses: when blood pressure rises in hypertension, doctors adjust medication and lifestyle plans rather than concluding treatment is useless. The same applies to disorders involving drug and alcohol use. View relapse as important clinical information to bring back to your treatment team, not as a reason to give up on sobriety.

When should someone consider returning to rehab after a relapse?

Consider a higher level of care, such as intensive outpatient or residential rehab, if return to use is frequent, control over use is slipping, withdrawal symptoms are severe, or safety is at risk through overdose, self-harm, or unsafe behaviors. For those considering residential care, practical guides on what to bring to rehab for addiction and mental health can reduce anxiety about the transition.

A qualified professional can assess whether residential treatment, intensive outpatient care, standard outpatient treatment, medication management, or another response is appropriate. Suspected overdose, severe withdrawal, self-harm risk, or another immediate danger requires emergency assistance rather than a routine admissions assessment.

Icarus Wellness and Recovery can help assess whether someone needs a full return to rehab, a step-up in outpatient services, or targeted changes to their relapse prevention plan. Reaching out is always the right call.

References

1. Brecht, M. L., & Herbeck, D. (2014). Time to relapse following treatment for methamphetamine use: A long-term perspective on patterns and predictors. Drug and Alcohol Dependence, 139, 18–25.
2. Centers for Disease Control and Prevention. (2025, June 9). Fentanyl.
3. Marlatt, G. A., & Donovan, D. M. (Eds.). (2005). Relapse prevention: Maintenance strategies in the treatment of addictive behaviors (2nd ed.). Guilford Press.
4. McHugh, R. K., Hearon, B. A., & Otto, M. W. (2010). Cognitive behavioral therapy for substance use disorders. Psychiatric Clinics of North America, 33(3), 511–525.
5. McLellan, A. T., Lewis, D. C., O’Brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA, 284(13), 1689–1695.
6. Nguyen, L. C., Durazzo, T. C., Dwyer, C. L., Rauch, A. A., Humphreys, K., Williams, L. M., & Padula, C. B. (2020). Predicting relapse after alcohol use disorder treatment in a high-risk cohort: The roles of anhedonia and smoking. Journal of Psychiatric Research, 126, 1–7.
7. Simpson, D. D., Joe, G. W., Fletcher, B. W., Hubbard, R. L., & Anglin, M. D. (1999). A national evaluation of treatment outcomes for cocaine dependence. Archives of General Psychiatry, 56(6), 507–514.
8. Substance Abuse and Mental Health Services Administration. (n.d.). What is substance use disorder?
9. TRICARE. (2025, December 5). Substance use disorder treatment.
10. Ware, O. D., Rodríguez, A. M., Cunningham, T., Appa, A., Lum, P. J., & Westbrook, M. (2025). Return to opioid use following discharge from non-hospital residential treatment for opioid use disorder: A systematic review. Substance Abuse and Rehabilitation, 16, 1–13.